Account wins

Share this article:
Centron has announced the following new agency of record assignments. Eisai has selected Centron as the advertising agency of record for their CTCL oncology portfolio, which includes ONTAK (denileukin diftitox), Targretin (bexarotene) capsules, and Targretin (bexarotene) gel 1.1%. Millennium Pharmaceuticals, has awarded Centron the advertising agency of record assignment for Velcade (bortezomib) for injection, their product for multiple myeloma and mantle cell lymphoma. Centron also announces that they have received additional assignments from Stiefel Laboratories, with agency of record assignments for Soriatane (acitretin), MimyX Cream, Olux-E (clobetasol propianate) Foam 0.05%, Verdeso (desonide) Foam, 0.05%, Olux (clobetasol propionate) Foam, 0.05%, and Luxiq (betamethasone valerate) Foam, 0.12%.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.